MINNELIDE, A PROMISING COMPOUND FOR THE TREATMENT OF HIGH-RISK MEDULLOBLASTOMA

被引:0
|
作者
Blanco, Jezabel Rodriguez [1 ]
Salvador, April [1 ]
Sahani, Pritika [1 ]
Kliebe, Valentin [1 ]
Peterson, Kendell [1 ]
Turos, Maria [1 ]
机构
[1] Med Univ South Carolina, Charleston, SC USA
关键词
D O I
10.1093/neuonc/noae064.555
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
MDB-107
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Trimodal therapy a promising alternative for high-risk patients
    Rebecca Drake
    Nature Reviews Urology, 2010, 7 (2) : 59 - 59
  • [22] Promising survival rate but high incidence of treatment-related mortality after reduced-dose craniospinal radiotherapy and tandem high-dose chemotherapy in patients with high-risk medulloblastoma
    Lee, Ji Won
    Lim, Do Hoon
    Sung, Ki Woong
    Cho, Hee Won
    Ju, Hee Young
    Hyun, Ju Kyung
    Yoo, Keon Hee
    Koo, Hong Hoe
    Suh, Yeon-Lim
    Joung, Yoo-Sook
    Shin, Hyung Jin
    CANCER MEDICINE, 2020, 9 (16): : 5807 - 5818
  • [23] SEVERE NEUROTOXICITY FOLLOWING HYPERFRACTIONATED ACCELERATED RADIOTHERAPY AND THIOTEPA IN THE TREATMENT OF HIGH-RISK MEDULLOBLASTOMA: THE UK EXPERIENCE
    Hayden, J.
    Vivekanandan, S.
    Thorp, N.
    Mayles, H.
    Baker, A.
    Pizer, B.
    Horan, G.
    PEDIATRIC BLOOD & CANCER, 2015, 62 : S172 - S173
  • [24] Long-term temozolomide treatment of high-risk medulloblastoma/PNET is feasible with low toxicity and high quality of life
    Fruehwald, Michael C.
    Grotzer, Michael
    Juergens, Heribert
    Straeter, Ronald
    NEURO-ONCOLOGY, 2008, 10 (03) : 483 - 483
  • [25] Treatment of High-Risk Neuroblastoma
    Hizhnikov, A.
    Kazancev, A.
    Kerimov, P.
    Pimenov, R.
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S447 - S447
  • [26] Young children with medulloblastoma: important open questions and the high-risk dilemma
    Mynarek, Martin
    Rutkowski, Stefan
    NEURO-ONCOLOGY, 2020, 22 (12) : 1723 - 1724
  • [27] YB-1-A NOVEL THERAPEUTIC TARGET IN HIGH-RISK MEDULLOBLASTOMA?
    Taylor, Louisa
    Kerr, Ian
    Coyle, Beth
    NEURO-ONCOLOGY, 2020, 22 : 405 - 405
  • [28] PLK4 is a rational target for very high-risk medulloblastoma
    Nor, Carolina
    Bray, Mark
    Mak, Tak
    Taylor, Michael
    CANCER RESEARCH, 2018, 78 (13)
  • [29] TREATMENT OF HIGH-RISK CHORIOCARCINOMA
    BAGSHAWE, KD
    JOURNAL OF REPRODUCTIVE MEDICINE, 1984, 29 (11) : 813 - 820
  • [30] Limitations of radiosensitization by direct telomerase inhibition to treat high-risk medulloblastoma
    Sengupta, Satarupa
    Kumar, Shiva Senthil
    Bondra, Kathryn
    Sobo, Matthew
    Mo, Xiaokui
    Drissi, Rachid
    FRONTIERS IN ONCOLOGY, 2023, 13